MINI FUTURE SHORT - ABBVIE Share Price

Certificat

DE000PD4RL25

Market Closed - Deutsche Boerse AG 01:20:28 20/06/2024 am IST
3.24 EUR +0.31% Intraday chart for MINI FUTURE SHORT - ABBVIE
Current month-24.53%
1 month-11.26%
Date Price Change
20/24/20 3.24 +0.31%
18/24/18 3.23 -5.00%
17/24/17 3.4 -2.58%
14/24/14 3.49 -5.16%
13/24/13 3.68 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 01:20 am IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying ABBVIE INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PD4RL2
ISINDE000PD4RL25
Date issued 08/04/2022
Strike 206 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.58
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.04
Lowest since issue 2.23

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
171.4 USD
Average target price
183.2 USD
Spread / Average Target
+6.93%
Consensus